Home
Trending
Briefing

Similar Stories 🔰

Zydus has launched Tishtha, an affordable biosimilar of nivolumab, at nearly one-fourth the original price. Approved by the Delhi High Court, the India-made immunotherapy aims to expand access to life-saving cancer treatment as cases rise nationwide, with nearly 15 lakh new diagnoses reported annually, according to Indian Council of Medical Research data. , Health, Times Now